Prognostic Value of Urinary Biomarkers in Proteinuria Progression in IgA Nephropathy Patients Treated with Budesonide

Prognostic Value of Urinary Biomarkers in Proteinuria Progression in IgA Nephropathy Patients Treated with Budesonide

<b><i>Background</i> & <i>Objectives</i>:</b> Targeted-release budesonide (TRB) is the first approved agent aimed at targeting the early pathogenetic cascade in IgA nephropathy (IgAN). <b><i>Materials and Methods</i>:</b> This prospecti...

Full description

Saved in:
Bibliographic Details
Main Authors: Christodoulos Keskinis, Eleni Moysidou, Stamatia Stai, Michalis Christodoulou, Georgios Lioulios, Sotirios-Spyridon Vamvakas, Maria Stella Trivyza, Panagiotis Pateinakis, Marios Papasotiriou, Maria Stangou
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Medicina
Subjects:
IgA nephropathy
targeted-release budesonide
urinary biomarkers
Monocyte Chemotactic Protein-1 (MCP-1)
Matrix MetalloProteinase-9 (MMP-9)
clusterin (CLU)
Online Access:https://www.mdpi.com/1648-9144/61/5/807
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1648-9144/61/5/807

Similar Items